Genmab A (GMAB) Shares Outstanding (Diluted Average): 2018-2020
- Genmab A's Shares Outstanding (Diluted Average) rose 15.58% to $7.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $7.6 million, marking a year-over-year increase of 15.58%. This contributed to the annual value of $7.6 million for FY2020, which is 15.58% up from last year.
- According to the latest figures from Q4 2020, Genmab A's Shares Outstanding (Diluted Average) is $7.6 million, which was up 15.58% from $6.6 million recorded in Q4 2019.
- In the past 5 years, Genmab A's Shares Outstanding (Diluted Average) registered a high of $7.6 million during Q4 2020, and its lowest value of $6.6 million during Q4 2019.
- For the 3-year period, Genmab A's Shares Outstanding (Diluted Average) averaged around $7.0 million, with its median value being $6.8 million (2018).
- In the last 5 years, Genmab A's Shares Outstanding (Diluted Average) dropped by 3.27% in 2019 and then grew by 15.58% in 2020.
- Over the past 3 years, Genmab A's Shares Outstanding (Diluted Average) (Quarterly) stood at $6.8 million in 2018, then fell by 3.27% to $6.6 million in 2019, then rose by 15.58% to $7.6 million in 2020.
- Its Shares Outstanding (Diluted Average) stands at $7.6 million for Q4 2020, versus $6.6 million for Q4 2019 and $6.8 million for Q4 2018.
